https://www.selleckchem.com/pr....oducts/liraglutide.h
BACKGROUND We investigated the impact of an elevated plasma volume status (PVS) in patients undergoing TAVI on early clinical safety and mortality, and assessed the prognostic utility of PVS for outcome prediction. MATERIALS AND METHODS We retrospectively calculated the PVS in 652 patients undergoing TAVI between 2009 and 2018 at two centers. They were then categorized into two groups depending on their preoperative PVS (PVS ≤-4; n= 257 vs. PVS -4; n=379). Relative PVS was derived by subtracting calculated ideal (iPVS = c × weig
Like
Comment
Share
